Get the Stockscreener App
1.305
8.74%
-0.125
After Hours:
1.33
0.025
+1.92%
Painreform Ltd stock is traded at $1.305, with a volume of 261.49K.
It is down -8.74% in the last 24 hours and down -4.04% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$1.43
Open:
$1.46
24h Volume:
261.49K
Relative Volume:
0.09
Market Cap:
$2.63M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.1828
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
-5.43%
1M Performance:
-4.04%
6M Performance:
-39.30%
1Y Performance:
-47.39%
1-Day Range:
$1.24
$1.46
1-Week Range:
$1.24
$1.4884
52-Week Range:
$1.24
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.305 | 2.88M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Painreform Ltd Stock (PRFX) Latest News
Risk vs reward if holding onto PainReform Ltd.July 2025 Rallies & Verified Momentum Stock Ideas - newser.com
Will PainReform Ltd. outperform the marketWeekly Trade Report & AI Enhanced Trade Execution Alerts - newser.com
What momentum shifts mean for PainReform Ltd.Market Performance Summary & Capital Protection Trading Alerts - newser.com
Can machine learning forecast PainReform Ltd. recoveryJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Chart based analysis of PainReform Ltd. trends2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Pattern recognition hints at PainReform Ltd. upsideQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
PainReform Announces H1 2025 Financial Results and Board Change - MSN
Should you hold or exit PainReform Ltd. nowMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com
Wall Street Zen Upgrades PainReform (NASDAQ:PRFX) to “Hold” - Defense World
Chart overlay techniques for tracking PainReform Ltd.Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
PainReform reports mixed progress in pharma and solar tech ventures By Investing.com - Investing.com Nigeria
PainReform Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Painreform provides business update for the six months ended June 30, 2025 - MarketScreener
Painreform Provides Business Update For The Six Months Ended June 30, 2025 - TradingView
PainReform (PRFX) Reports Transformative Developments in Pharmac - GuruFocus
PainReform reports mixed progress in pharma and solar tech ventures - Investing.com India
PainReform Ltd. Reports Business Update and Financial Results for First Half of 2025, Highlights Investment in LayerBio and Progress in Pharmaceutical and Smart Energy Divisions - Quiver Quantitative
PainReform Provides Business Update for the Six Months Ended June 30, 2025 - GlobeNewswire
$9B Market Opportunity: PainReform's New Dropless Cataract Therapy Could Transform Post-Surgery Care - Stock Titan
Is PainReform Ltd a good long term investmentMarket Correction Analysis & Rapid Profit Portfolio - earlytimes.in
What drives PainReform Ltd stock priceAnalyst Downgrades & Create Your Free Watchlist Instantly - Early Times
What analysts say about PainReform Ltd stockPrice Channel Trading & Free Turn Volatility To Profit - Early Times
Will PainReform Ltd. stock sustain high P E ratiosJuly 2025 Trends & Weekly Watchlist for Consistent Profits - The British Mountaineering Council
PainReform Enters Cataract Surgery Market with LayerBio Investment - MSN
PainReform Ltd. stock prediction for this weekQuarterly Earnings Report & Real-Time Volume Trigger Notifications - newser.com
PainReform (NASDAQ:PRFX) Cut to “Strong Sell” at Wall Street Zen - Defense World
Published on: 2025-09-20 23:16:59 - khodrobank.com
Technical signs of recovery in PainReform Ltd.Market Performance Report & Precise Buy Zone Tips - newser.com
Highs Report: Is PainReform Ltd stock a top performer YTD2025 Top Gainers & Technical Confirmation Alerts - خودرو بانک
How to interpret RSI for PainReform Ltd. stockVolume Spike & Verified Chart Pattern Signals - newser.com
Evaluating PainReform Ltd. with trendline analysisTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
How to recover losses in PainReform Ltd. stockJuly 2025 Patterns & Daily Profit Maximizing Tips - newser.com
Is PainReform Ltd. forming a bottoming base2025 Year in Review & Proven Capital Preservation Tips - newser.com
Momentum Shift: Can PainReform Ltd. maintain sales growth2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - خودرو بانک
Fund Flows: Why is PainReform Ltd stock going upJuly 2025 Review & Safe Capital Growth Tips - خودرو بانک
Sectors Review: Will PainReform Ltd outperform during market ralliesM&A Rumor & Entry Point Strategy Guides - خودرو بانک
Death Cross: Will PainReform Ltd stock benefit from M AJuly 2025 Reactions & Weekly High Conviction Trade Ideas - خودرو بانک
Tech Rally: Is PainReform Ltd. stock overvalued or fairly priced2025 Trade Ideas & Precise Buy Zone Tips - خودرو بانک
Insider Buy: Is PainReform Ltd attractive at current valuationMarket Activity Report & Community Trade Idea Sharing Platform - خودرو بانک
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):